Comment in

• A prescription for ethical learning. Commentary.

  Largent EA, Miller FG, Joffe S. Largent EA, et al. Hastings Cent Rep. 2013 Jan-Feb;Spec No:S28-9. doi: 10.1002/hast.135. Hastings Cent Rep. 2013. PMID: 23315890 No abstract available.
• The unbelievable rightness of being in clinical trials. Commentary.

  Menikoff J. Menikoff J. Hastings Cent Rep. 2013 Jan-Feb;Spec No:S30-1. doi: 10.1002/hast.136. Hastings Cent Rep. 2013. PMID: 23315891 No abstract available.
• Making the transition to a learning health care system. Commentary.

  Grady C, Wendler D. Grady C, et al. Hastings Cent Rep. 2013 Jan-Feb;Spec No:S32-3. doi: 10.1002/hast.137. Hastings Cent Rep. 2013. PMID: 23315892 No abstract available.
• Ethical oversight: serving the best interests of patients. Commentary.

  Selby JV, Krumholz HM. Selby JV, et al. Hastings Cent Rep. 2013 Jan-Feb;Spec No:S34-6. doi: 10.1002/hast.138. Hastings Cent Rep. 2013. PMID: 23315893 No abstract available.
• Evaluation as part of operations: reconciling the common rule and continuous improvement. Commentary.

  Platt R, Grossmann C, Selker HP. Platt R, et al. Hastings Cent Rep. 2013 Jan-Feb;Spec No:S37-9. doi: 10.1002/hast.139. Hastings Cent Rep. 2013. PMID: 23315894 No abstract available.
• Reform within the common rule? Commentary.

  Puglisi T. Puglisi T. Hastings Cent Rep. 2013 Jan-Feb;Spec No:S40-2. doi: 10.1002/hast.140. Hastings Cent Rep. 2013. PMID: 23315896 No abstract available.
• Advances in the research enterprise. Commentary.

  Kupersmith J. Kupersmith J. Hastings Cent Rep. 2013 Jan-Feb;Spec No:S43-4. doi: 10.1002/hast.141. Hastings Cent Rep. 2013. PMID: 23315897 No abstract available.